Long term antibiotic therapy may be an effective treatment for children co-morbid with Lyme disease and Autism Spectrum Disorder

Medical Hypotheses

Volumn 78, Issue 5, 2012, Pages 606-615

  Kuhn, Mason ^a   Grave, Shannon ^a   Bransfield, Robert ^b   Harris, Steven ^c  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b Robert Wood Johnson School of Medicine   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; EPITOPE;

ANTIBIOTIC THERAPY; ANTIGENICITY; ARTICLE; AUTISM; AUTOIMMUNITY; BORRELIA BURGDORFERI; BRAIN PERFUSION; CASE REPORT; CHILD; CHILD BEHAVIOR; CHILDHOOD DISEASE; CHRONIC DISEASE; COMORBIDITY; DISEASE COURSE; HUMAN; HYPOTHESIS; INFLAMMATION; LONG TERM CARE; LYME DISEASE; MALE; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; PREVALENCE; PSYCHOLOGIC ASSESSMENT; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP; SOCIAL INTERACTION; SPEECH; STATISTICAL ANALYSIS; SYMPTOM; TEMPORAL LOBE; TREATMENT RESPONSE; VERBAL COMMUNICATION;

ANTI-BACTERIAL AGENTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; COMORBIDITY; HUMANS; INFANT; LYME DISEASE; MALE; MODELS, BIOLOGICAL; TIME FACTORS; TREATMENT OUTCOME; VERBAL BEHAVIOR;

EID: 84859265044     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.01.037     Document Type: Article

References (39)

1. Alaedini A., Latov N. Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue. J Neuroimmunol 2005, 159:192-195.
2. Adams W.V., Rose C.D., Eppes S.C., Klein J.D. Cognitive effects of Lyme disease in children. Pediatrics 1994, 94:185-189.
3. American Autoimmune and Related Disease Association. Autoimmune disorders. Cause, retrieved from: ; 2011. http://www.aarda.org/.
4. American Psychiatric Association. Pervasive developmental disorders. In: Diagnostic and statistical manual of mental disorders. 4th ed.- text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000. pp. 69-70.
5. Ashwood P., Wills S., Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol 2006, 80:1-15.
6. Autism Speaks. Autism Speaks: Science answers, < ; 2010 [retrieved 18.2.2011]. http://www.action.autismspeaks.org/page/content/scienceanswers.
7. Blumer D., Benson D. Personality changes with frontal and temporal lesions. Psychiatric aspects of neurologic disease 1975, Grune & Stratton, New York. D.F. Benson, F. Blumer (Eds.).
8. Bransfeld R.C. Lyme disease, comorbid tick-borne diseases, and neuropsychiatric disorders. Psychiatric Times 2007, 24:29-32.
9. Bransfield R.C., Wulfman J.S., Harvey W.T., Usman A.I. The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders. Med Hypotheses 2008, 70(5):967-974.
10. Cameron D. Treatment delay as a risk factor for treatment failure in Lyme disease. In: 16th International scientific conferemce on Lyme disease and other tick-borne disorders, Hartford, CT: 2003. [June 7-8 (abstract)].
11. Centers for Disease Control and Prevention. Lyme disease United States. Morbidity and Mortality Weekly, Report. 2007; 56(23): pp. 573-576.
12. Centers for Disease Control and Prevention. Autism Spectrum Disorders (ASDs): facts about ASDs, ; 2010a [retrieved 10.2.2011]. http://www.cdc.gov/ncbddd/autism/facts.html.
13. Centers for Disease Control and Prevention. Lyme disease, ; 2010b [retrieved 22.1.2011]. http://www.cdc.gov/ncidod/dvbid/lyme/index.htm.
14. Centers for Disease Control and Prevention. Reported Lyme disease cases by state, 1995-2009, ; 2010c [retrieved 25.1.2011]. http://www.cdc.gov/ncidod/dvbid/lyme/ld_rptdLymeCasesbyState.htm.
15. Comi A., Zimmerman A., Frye V., Law P., Joseph N. Antibodies against OspA epitopes of Borrelia burgdorferi familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 1999, 14:388-394. 10.1177/088307389901400608.
16. Dorland's Medical Dictionary for Health. Definition. hypoperfusion, retrieved from ; 2007. http://www.medical-dictionary.thefreedictionary.com/hypoperfusion.
17. Fallon B.A., Keilp J.G., Corbera K.M., Petkova E., Britton C.B., Dwyer E., et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2007, 70(13):922-1003. 10.1212/01.WNL.0000284604.61160.2d.
18. Fallon B., Nields J. Lyme disease: a neuropsychiatric illness. Am J Psychiatry 1994, 151(11):1571-1583.
19. Foxx R. Applied behavior analysis treatment of autism: the state of the art. Child and adolescent psychiatric clinics of North America 2008, 17(4):821-834.
20. Gendry Meresse I., Zilbovicius M., Boddaert N., Robel L., Philippe A., Sfaello I., et al. Autism severity and temporal lobe functional abnormalities. Ann Neurol 2005, 58(3):466-469.
21. Hamlen R.A., Kilman D.S. Lyme disease: etilogy, neuropsychological sequelae, and educational impact. Newspaper of the National Association of School Psychologists 2007, 35(5):34-38.
22. Harvard School of Public Health. Autism has high costs to US Society, retrieved from ; 2006. http://www.hsph.harvard.edu/news/press-releases/2006-releases/press04252006.html.
23. Helt M., Kelley E., Kinsbourne M., Pandey J., Boorstein H., Herbert M., et al. Can children with autism recover? If so, how?. Neuropsychol Rev 2011, 18(4):339-366. 10.1007/s11065-008-9075-9.
24. Kolb B., Whishaw I. Fundamentals of human neuropsychology 1990, W.H. Freeman and Co., New York.
25. Logigian E.L., Johnson K.A., Kijewski M.F., Kaplan R.F., Becker J.A., Jones K.J., et al. Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology 1997, 49:1661-1670.
26. MacDonald A.B. Gestational lyme borreliosis. Implications for the fetus. Rheum Dis Clin North Am 1989, 15(4):657-677.
27. Merriam-Webster's Medical Dictionary. Perseveration, ; 2007 [retrieved 3.3.2011]. http://www.dictionary.reference.com/browse/perseveration.
28. National Institute of Allergy and Infectious Disease. Lyme disease: the role of autoimmune reactivity, retrieved from ; 2007. http://www.niaid.nih.gov/topics/lymedisease/research/pages/autoimmune.aspx.
29. National Institute of Health. Autoimmune disorders, retrieved from ; 2010. http://www.nlm.nih.gov/medlineplus/ency/article/000816.htm.
30. National Institute of Mental Health. Autism Spectrum Disorders: Persuasive Developmental Disorders. (NIH Publication No. 08-5511). Washington, DC: U.S. Government Printing, Office; 2008.
31. National Network For Child Care. Developmental milestones: A guide for parents, retrieved from ; 1994. http://www.nncc.org/Child.Dev/mile1.html.
32. Pachner A. Neurologic manifestations of Lyme Disease, the new " Great Imitator" Clin Infect Dis 1989, 11(Suppl. 6):S1482-S1486. [doi:10.1093]Please provide the full detail of " doi number" for the Ref. [32].
33. Prizant BM, Wetherby AM, Rubin E, Amy Laurent C, Rydell PJ. In: Paul H, editor. The SCERTS® model a comprehensive educational approach for children with autism spectrum disorders, Baltimore, MD: Brookes Publishing Co; 2003.
34. Richler J., Luyster R., Risi S., et al. Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? a CPEA study. J Autism Dev Disord 2006, 36(3):299-316. [PMID 16729252]. 10.1007/s10803-005-0070-1.
35. Stefanatos G.A. Regression in autistic spectrum disorders. Neuropsychol Rev 2008, 18(4):305-319. [PMID]. 10.1007/s11065-008-9073-y.
36. Strickter R, Lautin A, Burrascano J. Lyme disease: point/counterpoint. Expert Rev Anti Infect Ther 2005; 3(2): doi:10.1586/14787210.3.2.
37. Thoughtful House For Children. Autism state ranking prevalence, retrieved from ; 2010. http://www.thoughtfulhouse.org/tech-labs/disabilities/autism-state-rankings-prevalence.php.
38. Vojdani A. Immunology of Lyme disease and associated disorders. LIA Conference 2007.
39. Zilbovicius M., Boddaert N., Belin P., Poline J.B., Remy P., Mangin J.F., et al. Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography. Am J Psychiatry 2000, 157:1988-1993.